256 Newsroom — Uganda's Digital News Infrastructure
Business

Novartis Reports 3 Patient Deaths. Why the Stock Is Heading for Its Best Day Since 2023. - Barron's

Published by Barron's By Mackenzie Tatananni · 1 September 2026 at 20:44
Share
Novartis Reports 3 Patient Deaths. Why the Stock Is Heading for Its Best Day Since 2023. - Barron's
Image · Barron's

What the report says

Novartis pauses clinical trials for rap-cel in patients with autoimmune disease, while reporting positive data for a different potential blockbuster.

Read the full report at Barron's →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Uganda’s informal economy seeks strength in numbersThe Observer 256 Newsroom Gen Saleh Calls for Review of Caged-Fishing and Coffee-Farming Projects - ChimpReportsChimpReports 256 Newsroom King Oyo’s legacy: How a boy monarch redefined Uganda’s cultural resilience - monitor.co.ugDaily Monitor Gen. Saleh Calls For Review Of Caged-Fishing And Coffee-Farming ProjectsWatchdog Uganda Rubanda Launches Shs40m Road Project to Boost Farm-to-Market AccessNile Post 256 Newsroom Nabacwa's purse strings and FTB's promise: Women's football learns to bank on itself - Daily MonitorDaily Monitor